Market revenue in 2023 | USD 76.7 million |
Market revenue in 2030 | USD 109.2 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.96% in 2023. Horizon Databook has segmented the Brazil implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The ICD device market in Brazil is driven by the increasing prevalence of CVD in the country. According to the Gagnon-Arpin 2017 study, the number of Brazilian adults affected by CVD will reach 13.6 million by 2035.
This upward trend in CVD prevalence is expected to increase the demand for advanced diagnosis and treatment options, including ICDs. Consequently, the market for ICD devices is expected to experience significant growth.
Furthermore, the economic impact of CVDs serves as an additional driving factor in the market for ICDs. The study further states that the associated economic burden, encompassing direct and indirect costs, would surge to USD 40 billion.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Brazil implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account